TY - JOUR
T1 - Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials
AU - Ramachandran, Gurumurthy
AU - Howard, John
AU - Maynard, Andrew
AU - Philbert, Martin
PY - 2012/12
Y1 - 2012/12
N2 - The article focuses on issues relating to occupational exposures of researchers and lab workers, and exposures of bystanders such as health care workers and family members during HSR using nanomaterials. Such third-party exposures give rise to unique challenges relating to oversight as well as exposures to worker groups not previously studied. Given the current state of knowledge regarding health risks from such exposures, a more precautionary approach to oversight seems advisable.
AB - The article focuses on issues relating to occupational exposures of researchers and lab workers, and exposures of bystanders such as health care workers and family members during HSR using nanomaterials. Such third-party exposures give rise to unique challenges relating to oversight as well as exposures to worker groups not previously studied. Given the current state of knowledge regarding health risks from such exposures, a more precautionary approach to oversight seems advisable.
UR - http://www.scopus.com/inward/record.url?scp=84872159536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872159536&partnerID=8YFLogxK
U2 - 10.1111/j.1748-720X.2012.00714.x
DO - 10.1111/j.1748-720X.2012.00714.x
M3 - Article
C2 - 23289688
AN - SCOPUS:84872159536
SN - 1073-1105
VL - 40
SP - 856
EP - 864
JO - Journal of Law, Medicine and Ethics
JF - Journal of Law, Medicine and Ethics
IS - 4
ER -